Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma

Ryota Tamura, Kentaro Ohara, Hikaru Sasaki, Yukina Morimoto, Kenzo Kosugi, Kazunari Yoshida, Masahiro Toda

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Vascular endothelial growth factor (VEGF)-A and VEGF receptor expression in the peritumoral brain zone (PBZ) differs from that in the tumor core (TC) of glioblastoma. To date, no comparative study has investigated the expression of immunosuppressive cells in the PBZ and TC of glioblastoma. Methods: In 10 patients with newly diagnosed glioblastoma, we used immunohistochemistry to analyze the expression of VEGF-A, hypoxia-inducible factor-1α, programmed cell death-1 (PD-1), Foxp3, CD163, CD4, and CD8 to assess the immunosuppressive microenvironment. Results: The number of Foxp3+ and CD163+ cells was significantly greater in the TC than in the PBZ and correlated with greater expression of hypoxia-inducible factor-1α and VEGF-A in the TC than in the PBZ. The number of CD8+ T cells was lower in the TC than in the PBZ, and the TC had more PD-1+CD8+ T cells compared with the PBZ. These results suggest that the hypoxic condition could be associated with PD-1 expression on lymphocytes, the distribution of Foxp3+ regulatory T cells and CD163+ tumor-associated macrophages. Conclusions: The present study reports the first clinicopathologic features of the differences in immunosuppressive cells and the expression of immune checkpoint molecules between the TC and PBZ of glioblastoma.

Original languageEnglish
JournalWorld Neurosurgery
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Glioblastoma
Immunosuppressive Agents
Vascular Endothelial Growth Factor A
Brain
Hypoxia-Inducible Factor 1
Neoplasms
Cell Death
Brain Neoplasms
T-Lymphocytes
Vascular Endothelial Growth Factor Receptor
Regulatory T-Lymphocytes
Immunohistochemistry
Macrophages
Lymphocytes

Keywords

  • Lymphocytes
  • PD-1
  • Peritumoral brain zone
  • TAM
  • Treg
  • VEGF

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma. / Tamura, Ryota; Ohara, Kentaro; Sasaki, Hikaru; Morimoto, Yukina; Kosugi, Kenzo; Yoshida, Kazunari; Toda, Masahiro.

In: World Neurosurgery, 01.01.2018.

Research output: Contribution to journalArticle

@article{84cddfedb5b64328b1d780a9d78cee46,
title = "Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma",
abstract = "Background: Vascular endothelial growth factor (VEGF)-A and VEGF receptor expression in the peritumoral brain zone (PBZ) differs from that in the tumor core (TC) of glioblastoma. To date, no comparative study has investigated the expression of immunosuppressive cells in the PBZ and TC of glioblastoma. Methods: In 10 patients with newly diagnosed glioblastoma, we used immunohistochemistry to analyze the expression of VEGF-A, hypoxia-inducible factor-1α, programmed cell death-1 (PD-1), Foxp3, CD163, CD4, and CD8 to assess the immunosuppressive microenvironment. Results: The number of Foxp3+ and CD163+ cells was significantly greater in the TC than in the PBZ and correlated with greater expression of hypoxia-inducible factor-1α and VEGF-A in the TC than in the PBZ. The number of CD8+ T cells was lower in the TC than in the PBZ, and the TC had more PD-1+CD8+ T cells compared with the PBZ. These results suggest that the hypoxic condition could be associated with PD-1 expression on lymphocytes, the distribution of Foxp3+ regulatory T cells and CD163+ tumor-associated macrophages. Conclusions: The present study reports the first clinicopathologic features of the differences in immunosuppressive cells and the expression of immune checkpoint molecules between the TC and PBZ of glioblastoma.",
keywords = "Lymphocytes, PD-1, Peritumoral brain zone, TAM, Treg, VEGF",
author = "Ryota Tamura and Kentaro Ohara and Hikaru Sasaki and Yukina Morimoto and Kenzo Kosugi and Kazunari Yoshida and Masahiro Toda",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.wneu.2018.08.133",
language = "English",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma

AU - Tamura, Ryota

AU - Ohara, Kentaro

AU - Sasaki, Hikaru

AU - Morimoto, Yukina

AU - Kosugi, Kenzo

AU - Yoshida, Kazunari

AU - Toda, Masahiro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Vascular endothelial growth factor (VEGF)-A and VEGF receptor expression in the peritumoral brain zone (PBZ) differs from that in the tumor core (TC) of glioblastoma. To date, no comparative study has investigated the expression of immunosuppressive cells in the PBZ and TC of glioblastoma. Methods: In 10 patients with newly diagnosed glioblastoma, we used immunohistochemistry to analyze the expression of VEGF-A, hypoxia-inducible factor-1α, programmed cell death-1 (PD-1), Foxp3, CD163, CD4, and CD8 to assess the immunosuppressive microenvironment. Results: The number of Foxp3+ and CD163+ cells was significantly greater in the TC than in the PBZ and correlated with greater expression of hypoxia-inducible factor-1α and VEGF-A in the TC than in the PBZ. The number of CD8+ T cells was lower in the TC than in the PBZ, and the TC had more PD-1+CD8+ T cells compared with the PBZ. These results suggest that the hypoxic condition could be associated with PD-1 expression on lymphocytes, the distribution of Foxp3+ regulatory T cells and CD163+ tumor-associated macrophages. Conclusions: The present study reports the first clinicopathologic features of the differences in immunosuppressive cells and the expression of immune checkpoint molecules between the TC and PBZ of glioblastoma.

AB - Background: Vascular endothelial growth factor (VEGF)-A and VEGF receptor expression in the peritumoral brain zone (PBZ) differs from that in the tumor core (TC) of glioblastoma. To date, no comparative study has investigated the expression of immunosuppressive cells in the PBZ and TC of glioblastoma. Methods: In 10 patients with newly diagnosed glioblastoma, we used immunohistochemistry to analyze the expression of VEGF-A, hypoxia-inducible factor-1α, programmed cell death-1 (PD-1), Foxp3, CD163, CD4, and CD8 to assess the immunosuppressive microenvironment. Results: The number of Foxp3+ and CD163+ cells was significantly greater in the TC than in the PBZ and correlated with greater expression of hypoxia-inducible factor-1α and VEGF-A in the TC than in the PBZ. The number of CD8+ T cells was lower in the TC than in the PBZ, and the TC had more PD-1+CD8+ T cells compared with the PBZ. These results suggest that the hypoxic condition could be associated with PD-1 expression on lymphocytes, the distribution of Foxp3+ regulatory T cells and CD163+ tumor-associated macrophages. Conclusions: The present study reports the first clinicopathologic features of the differences in immunosuppressive cells and the expression of immune checkpoint molecules between the TC and PBZ of glioblastoma.

KW - Lymphocytes

KW - PD-1

KW - Peritumoral brain zone

KW - TAM

KW - Treg

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=85053703097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053703097&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2018.08.133

DO - 10.1016/j.wneu.2018.08.133

M3 - Article

C2 - 30165233

AN - SCOPUS:85053703097

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -